OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
Marjan Mojtabavi Naeini, Felicity Newell, Lauren G. Aoude, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Marjan Mojtabavi Naeini, Felicity Newell, Lauren G. Aoude, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Advances in diagnosis and management of cancer of the esophagus
Nathaniel Deboever, Christopher M. Jones, Kohei Yamashita, et al.
BMJ (2024), pp. e074962-e074962
Open Access | Times Cited: 31
Nathaniel Deboever, Christopher M. Jones, Kohei Yamashita, et al.
BMJ (2024), pp. e074962-e074962
Open Access | Times Cited: 31
Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective
Zhi Yang, Fada Guan, Lawrence F. Bronk, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108591-108591
Closed Access | Times Cited: 11
Zhi Yang, Fada Guan, Lawrence F. Bronk, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108591-108591
Closed Access | Times Cited: 11
Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy
Sandra Brosda, Lauren G. Aoude, Vanessa Bonazzi, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Sandra Brosda, Lauren G. Aoude, Vanessa Bonazzi, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
James M. Lonie, Sandra Brosda, Vanessa Bonazzi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
James M. Lonie, Sandra Brosda, Vanessa Bonazzi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
HDACs alters negatively to the tumor immune microenvironment in gynecologic cancers
Yan Miao, Heng Cao, Kangjia Tao, et al.
Gene (2023) Vol. 885, pp. 147704-147704
Open Access | Times Cited: 3
Yan Miao, Heng Cao, Kangjia Tao, et al.
Gene (2023) Vol. 885, pp. 147704-147704
Open Access | Times Cited: 3
Repurposing of the PET Probe Prototype PiB for Label and Radiation-Free CEST MRI Molecular Imaging of Amyloid
Caiyu Zhuang, Beibei Chen, Shuohua Wu, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 24, pp. 4344-4351
Open Access | Times Cited: 3
Caiyu Zhuang, Beibei Chen, Shuohua Wu, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 24, pp. 4344-4351
Open Access | Times Cited: 3
Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma
Clémence Belle, James M. Lonie, Sandra Brosda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Clémence Belle, James M. Lonie, Sandra Brosda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Karen van der Sluis, Johanna W. van Sandick, Willem J. Koemans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Karen van der Sluis, Johanna W. van Sandick, Willem J. Koemans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease
Fiona Day, Swetha Sridharan, Catherine Johnson, et al.
Asia-Pacific Journal of Clinical Oncology (2024) Vol. 20, Iss. 3, pp. 416-422
Open Access
Fiona Day, Swetha Sridharan, Catherine Johnson, et al.
Asia-Pacific Journal of Clinical Oncology (2024) Vol. 20, Iss. 3, pp. 416-422
Open Access
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma.
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Dimitra Peristeri, Munir Tarazi, Patrick J. Casey, et al.
Best Practice & Research Clinical Gastroenterology (2024) Vol. 72, pp. 101954-101954
Closed Access
Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas
Karen van der Sluis, Johanna W. van Sandick, Willem J. Koemans, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114981-114981
Open Access
Karen van der Sluis, Johanna W. van Sandick, Willem J. Koemans, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114981-114981
Open Access
The future of combination immunotherapy in oesophageal adenocarcinoma
Maria Davern, Noel E. Donlon
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Maria Davern, Noel E. Donlon
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
